Type 2 diabetes patients are at a higher risk for peptic ulcer bleeding….
Read More »Walking Versus Running to Reduce Risk of Chronic Diseases
Which is better at lowering risk for high blood pressure, cholesterol, and diabetes?…
Read More »Obesity without Health Problems: A New Inflammatory Marker Discovered
A marker called AIM (apoptosis inhibitor of macrophage) is an important factor in the autoimmune process. The inhibition of AIM may stop the body from producing antibodies which attack the self….
Read More »Newly Designed Primary Care Services to Optimize A1c
A cohort study of 727 African-American patients with type 2 diabetes was conducted using interventions such as point-of-care education, coaching, and medication intensification from a team of a nurse, pharmacist, and dietitian….
Read More »Importance of Oral Health in Diabetes
A new European study shows an association between type 2 diabetes and chronic periodontitis….
Read More »First In Class Medication Approved for Type 2 Diabetes
The FDA has approved Invokana (canaglifozin), the first in its class of sodium-glucose co-transporter 2 (SGLT2) inhibitors. Johnson & Johnson’s new drug is used to treat type 2 diabetes in conjunction with diet and exercise….
Read More »Metformin May Slow Aging Process
Worms treated with metformin live longer. The drug may slow the aging process by mimicking the effects of dieting….
Read More »Insulin Requirements Increased by High-Fat Meals
An increase in dietary fat can raise glucose levels and insulin requirements in patients with type 1 diabetes….
Read More »Metformin May Delay Aging and Cancer Progression
Metformin delays aging and cancer progression by reducing the production of….
Read More »Marijuana Does Not Have Long-lasting Metabolic Effects
Marijuana used regularly has little impact on the overall metabolism of glucose and lipids….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.